Singapore is taking another step towards treating COVID-19 as a long-term public health challenge, with the government set to incorporate COVID-19 vaccination into the country’s national childhood and adult immunisation schedules from October 12.
The Ministry of Health (MOH) said the decision reflects the continued circulation of the virus and the persistent risk of severe illness, particularly among older people and those with underlying medical vulnerabilities.
Under the new arrangement, updated COVID-19 vaccines will be available at more than 600 general practitioner clinics, all polyclinics and Mobile Vaccination Team sites across the island.
The programme will particularly target people aged 60 and above, medically vulnerable individuals aged six months and older, as well as residents of aged-care facilities. Healthcare workers and people who live or work closely with medically vulnerable individuals are also being encouraged to receive the vaccine.
The move represents a significant evolution in Singapore’s approach to a virus that once brought much of the country’s daily life to a standstill.
Singapore recorded its first COVID-19 case on January 23, 2020. In the months that followed, the country introduced some of the region’s strictest measures to contain transmission, including the “circuit breaker” from April 7 to June 1, 2020, which saw schools and non-essential workplaces closed.
The country began its COVID-19 vaccination programme in early 2021, initially deploying mRNA vaccines developed by Pfizer-BioNTech and Moderna. By the middle of 2022, more than 92 per cent of Singapore’s population had completed their primary vaccination series.
Since then, Singapore has gradually moved away from emergency containment measures towards managing COVID-19 alongside other respiratory illnesses.
The latest policy reflects that transition. Rather than relying on broad restrictions, the country is maintaining surveillance through variant monitoring, wastewater testing and regular public health updates while focusing vaccination efforts on people most at risk of serious disease.
For Singapore, the shift illustrates how the pandemic has entered a new phase: no longer an emergency requiring widespread disruption of society, but a continuing health threat that requires sustained monitoring and protection of vulnerable populations.
The inclusion of COVID-19 vaccination in routine national immunisation schedules also signals a longer-term approach to living with the virus, with vaccination remaining an important tool for reducing the risk of severe illness among those most vulnerable.
Four years after the pandemic transformed everyday life across the world, Singapore’s evolving strategy highlights a broader global reality: COVID-19 may have receded from the headlines, but it has not disappeared—and governments are increasingly adapting their health systems to manage its continuing presence.
